There may be a way to get the $50 GLP-1 Bridge price, because the mere fact that xxx quotes a roughly $400 cost does not by itself disqualify the client.
The critical distinction
The Medicare GLP-1 Bridge operates outside the client’s xxx Part D coverage. xxx does not have to approve or participate in the Bridge. An HMO-POS Medicare Advantage plan with Part D, such as the xxx plan, is an eligible plan type. (Centers for Medicare & Medicaid Services)
The uploaded plan summary shows why the pharmacy may be quoting around $400: Tier 4 drugs have 42% coinsurance, Tier 5 drugs have 29% coinsurance, and Tiers 3–5 are subject to a $355 deductible. That is not necessarily a fixed $400 copayment. The plan’s 2026 Part D out-of-pocket ceiling is $2,100.
The client generally cannot use the Bridge when:
-
The GLP-1 is being prescribed for a condition already coverable under Part D, such as type 2 diabetes, moderate-to-severe obstructive sleep apnea or MASH.
-
The client is already receiving the GLP-1 through the Part D plan.
-
The drug is being prescribed for a Part D-covered indication rather than solely for weight management.
However, a client who is using the medication solely for weight management, meets the Bridge’s BMI and clinical requirements, and does not have one of the disqualifying diagnoses may qualify—even though the pharmacy initially ran the prescription through UHC and produced a $400 price. (Centers for Medicare & Medicaid Services)
What I would try immediately
Have the prescribing doctor issue a Bridge-covered prescription for:
-
Wegovy injection or tablet;
-
Foundayo tablet; or
-
Zepbound KwikPen.
The Zepbound single-dose pens and vials are not Bridge-covered. (Centers for Medicare & Medicaid Services)
The prescription should include:
E66 obesity diagnosis code
“SEND TO BRIDGE FOR WEIGHT MANAGEMENT”
CMS specifically instructs prescribers to put that language in the electronic prescription’s note field. The pharmacy should submit the claim directly to the Medicare GLP-1 Bridge, not first process it as a normal UHC Part D claim. (Centers for Medicare & Medicaid Services)
The Bridge pharmacy processing information is:
-
BIN: 028918
-
PCN: MEDDGLP1BR
-
Pharmacy Help Desk: 844-673-0910
-
Prescriber Bridge Call Center: 855-273-0102, Monday–Friday, 8 a.m.–7 p.m. Eastern. (Centers for Medicare & Medicaid Services)
After the pharmacy submits it, the Bridge ordinarily sends a prior-authorization request to the doctor within about 24–72 hours. If the Bridge denies it and the doctor believes the denial is mistaken, CMS permits the doctor to resubmit it for re-review. (Centers for Medicare & Medicaid Services)
What the doctor must establish
The medication must be prescribed to reduce excess body weight and maintain weight reduction, together with diet and physical activity. At the time GLP-1 treatment started, the client generally must have had:
-
BMI of at least 35; or
-
BMI of at least 30 with qualifying heart failure, uncontrolled hypertension or stage 3a-or-higher kidney disease; or
-
BMI of at least 27 with prediabetes, prior heart attack, prior stroke or symptomatic peripheral artery disease. (Centers for Medicare & Medicaid Services)
The prescriber should not change or omit a genuine diagnosis merely to obtain Bridge eligibility. The doctor signs the authorization under penalty of perjury, and CMS says it may check the client’s Medicare claims history. (Centers for Medicare & Medicaid Services)
If the client really is ineligible
Because you said the client has very little money, Extra Help should be checked immediately. In 2026, someone receiving Extra Help pays:
-
$0 Part D deductible;
-
$0 qualifying plan premium; and
-
no more than $12.65 for a covered brand-name drug.
The general 2026 limits are approximately $23,475 annual income and $18,090 in countable resources for one person, or $31,725 income and $36,100 resources for a married couple living together. Some income and resources are excluded, so it can be worth applying even when the person appears slightly over the limits. (Medicare)
If Extra Help is unavailable, the doctor can also ask xxx for a tiering exception, a preferred GLP-1 alternative or waiver of a formulary requirement. Medicare permits tiering exceptions when the prescriber explains why the preferred lower-cost drugs would not be effective or would cause adverse effects, although specialty-tier drugs may be exempt. (Medicare)
The Medicare Prescription Payment Plan could spread the approximately $400 expense over the remaining months, but it does not reduce the total cost. The client’s covered Part D spending is nevertheless capped at $2,100 for 2026. (Medicare)
My first move would therefore be to determine the exact drug, the diagnosis used on the prescription, whether the client has type 2 diabetes/OSA/MASH, and whether xxx has ever actually paid a GLP-1 claim. Those facts will tell us whether this is a genuine Bridge exclusion or simply a pharmacy-routing problem.